Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susan van Hal"'
Autor:
Onno Kranenburg, Hergen Spits, Julien Villaudy, Madalina Cercel, Miriam Koopman, Cornelis J A Punt, Jamila Laoukili, Andre Verheem, Inne H M Borel Rinkes, Emre Küçükköse, Balthasar A Heesters, Susan van Hal, Sylvia F Boj, Jeanine M L Roodhart
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Background The immunogenic nature of metastatic colorectal cancer (CRC) with high microsatellite instability (MSI-H) underlies their responsiveness to immune checkpoint blockade (ICB). However, resistance to ICB is commonly observed, and is associate
Externí odkaz:
https://doaj.org/article/bfcad88f61be41c09cf923011ef6cf7d
Autor:
Els Verdegaal, Hergen Spits, Remko Schotte, Martijn Kedde, Gemma Moiset, Hans Van Eenennaam, Pauline van Helden, Sjoerd van der Burg, Julien Villaudy, Wouter Pos, Daniel Go, Christien Fatmawati, Etsuko Yasuda, Madalina Cercel, Esmay Frankin, Susan van Hal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/db80a70a00dd4578b39f1f849964e0ec
Autor:
Susan van Hal, Pauline M. van Helden, Els M. E. Verdegaal, Daniel Go, Martijn Kedde, Madalina Cercel, Hans van Eenennaam, Esmay Frankin, Etsuko Yasuda, Hergen Spits, Christien Fatmawati, Julien Villaudy, Sjoerd H. van der Burg, Wouter Pos, Gemma Moiset, Remko Schotte
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Adaptive immunity to cancer cells forms a crucial part of cancer immunotherapy. Recently, the importance of tumor B-cell signatures were shown to correlate with melanoma survival. We investigated whether tumor-targeting antibodies could be
Autor:
Els M. E. Verdegaal, Piet Gros, Susan van Hal, Hans van Eenennaam, Hergen Spits, Julien Villaudy, Yvonne Claasen, Christien Fatmawati, Pauline M. van Helden, Viviana Neviani, Koen Wagner, Etsuko Yasuda, Martijn Kedde, Wouter Pos, Sjoerd H. van der Burg, Remko Schotte, Daniel Go
Publikováno v:
Cancer Research. 80:532-532
Background Adaptive immunity to cancer cells has been shown to form a crucial part of cancer immunotherapy. Recently, the importance of tumor B-cell signatures were shown to correlate with melanoma survival. We investigated whether anti-tumor antibod
Autor:
Mette D. Hazenberg, Hergen Spits, Anikó Szabó, Greta de Jong, Remko Schotte, Madalina Cercel, Hans van Eenennaam, Martijn Kedde, Etsuko Yasuda, Pauline M. van Helden, Els M. E. Verdegaal, Sjoerd H. van der Burg, Wouter Pos, Sophie E. Levie, Esmay Frankin, Julien Villaudy, Daniel Go, Susan van Hal, Anita van Rijneveld
Publikováno v:
Cancer Research. 80:531-531
Introduction Despite rapid advances in immunotherapeutic options for precursor B-acute lymphoblastic leukemia (BCP-ALL), outcomes remain poor especially for adult ALL and relapsed pediatric ALL. With conventional chemotherapy remission percentages in